Analysis of BRCA samples from various clinical subtypes in the TCGA revealed substantial correlations between MDH2 transcript levels and breast cancer subtype, pathological T stage, human epidermal growth factor receptor 2 (HER2) status, estrogen receptor (ER) status, progesterone receptor (PR) status, race, and histological type. This evidence concerns the gene MDH2 and breast carcinoma.